MIV-710

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameMIV-710
Drug Alias Namecathepsin K inhibitor (Medivir)MIV-710
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCathepsin K inhibitors
TargetsCathepsin K
Therapy Area/IndicationsBone metastasesOsteoarthritisOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMedivir AB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedivir AB
Active IndicationsN/A
Inactive IndicationsBone metastasesOsteoarthritisOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A